iGenetic Diagnostics and the Indian diagnostic sector

Do you know the diagnostic industry of our country is worth $9 billion? One such leading Indian pathology chain is Mumbai-based iGenetic Diagnostics.

Do you know the diagnostic industry of our country is worth $9 billion? It had a growth rate of a mere 6% in 2018 to having 20-25% in 2021. Within this, the high-end services constitute 9%.

In 2015 the Government of India under the aegis of National Health Mission launched the Free Diagnostic Service Initiative. This pushed all states and UTs to provide free cost essential diagnostics. In 2019, India became the first country where the government took the initiative to compile the National Essential Diagnostic List which mandates certain tests be available at the remotest of the village. The Union Budget 2020, kept ₹759 crores aside to make sure all Indian states can administer free diagnostic services. 

One such leading Indian pathology chain is Mumbai-based iGenetic Diagnostics. Launched in 2013 by Arunima Patel, Homer Paneri and Siddharth Patodia, it provides 1400 + general and advanced molecular diagnostics, genetic sequencing and cytogenetics tests.

The three founders were part of the healthcare sector and wanted to build a venture that used molecular biology in testing to create better and quicker lab results. For this, they build a dedicated team of scientists and researchers and launched their operations in 2015. Initially, they started with a seed fund worth ₹10 crores that was gained by numerous sources including the founders adding their own money. Later in 2015, they received ₹9 crores from an angel investor.

 Their biggest breakthrough was when the UK government’s financial institution, CDC Group Plc and Manipal Education and Medical Group (MEMG) invested ₹130 crores. With the funds, they plan to expand their operations from the current 4 locations in India. As of 2017, they had their headquarters in Mumbai and five satellite laboratories spread in Mumbai, Nagpur, Hyderabad and Ahmedabad. 

In 2018, iGenetic Diagnostics made a collaboration with Lucence Diagnostics. The latter is a Singapore-based genomic medicine company. The deal between these two allows Lucence Diagnostics’s liquid biopsy test to be available in India. Diagnostics is not only a great addition to preventive healthcare but also to the Indian economy. They save the lives of many by pre-screening major illnesses. This increases the overall productivity of our country’s citizens. Do you agree?

Tags : #iGeneticDiagnostics #GoI #NationalHealthMission #ArunimaPatel #HomerPaneri #SiddharthPatodia #LucenceDiagnostics #CDCGroupPlc #ManipalEducationandMedicalGroup #funding #corporatealert #startupfunding #medispeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Moscow Researchers Develop Russia's Pioneer Lumbosacral Spine Phantom for Anesthesia Ultrasound TrainingNovember 12, 2024
World Pneumonia Day: How Pneumonia Continues to Steal Lives and What We Can Do About ItNovember 12, 2024
From Darkness to Clarity: How Stem Cell Transplants Are Offering New Hope for Corneal BlindnessNovember 12, 2024
Daytime Sleepiness and Dementia: Is Napping in the Afternoon Putting You at Risk?November 12, 2024
GET WEDDING-READY WITH KAY BEAUTY: KATRINA KAIF’S TOP PICKS FOR BRIDES & BRIDESMAIDSNovember 11, 2024
Amrita Vishwa Vidyapeetham Students Win Global All-Track Grand Prize at HackHarvard 2024 Organized by Harvard University StudentsNovember 11, 2024
Algorand Foundation Announces its Investment in 5 Startups from the Inaugural Startup Lab Program at T-HubNovember 11, 2024
DOST, DTI & DICT join forces for Philippine Startup Week 2024 to Ignite Filipino InnovationNovember 11, 2024
Firewall gender equality from threats like anti-rights Geneva Consensus DeclarationNovember 11, 2024
Delhi’s Air Crisis: How Toxic Air and Pollution Are Still Threatening Health and Life QualityNovember 11, 2024
Are You at Risk? AI Data Exposes Unseen Triggers of Diabetes in Our EnvironmentNovember 11, 2024
Why Children in High-Risk Areas Are Paying the Price for TB Neglect?November 11, 2024
The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening InfectionsNovember 09, 2024
Is Your Gut Telling You Something? The Bacterial Clues to Early Rheumatoid ArthritisNovember 09, 2024
Newcastle University Announces VC Excellence Scholarships for Undergraduate and Postgraduate StudiesNovember 08, 2024
Beyond the X-ray: Celebrating the Pioneers of Radiography on World Radiography DayNovember 08, 2024
Digital Doctors and Village Heroes: Tackling Depression and Stigma in India’s HeartlandNovember 08, 2024
Why Are Food Giants Pushing ‘Low-Star’ Nutrition on Low-Income Countries?November 08, 2024
NokAir joins hands with Çelebi for world class ground handling services for newly launched Bangkok-Mumbai routeNovember 07, 2024
Why Are Rare Disease Patients Paying a Fortune When Local Production Could Save Lives?November 07, 2024